Hyo-Jung Park

Research professor

The Catholic University of Korea

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Collaborators (5)

Mee‐Sup Yoon

Seongeun Bae

International Vaccine Institute

Jae‐Hwan Nam

Soyeon Yoo

University of Pennsylvania

UNITED STATES

Youngran Cho

The Catholic University of Korea

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hyo-Jung Park

Research Interests

Explore related searches

Contact this professor

Articles (12)

Collaborators (5)

Mee‐Sup Yoon

Seongeun Bae

Jae‐Hwan Nam

Soyeon Yoo

Youngran Cho

Make your next move.

Hyo-Jung Park

Research Interests

Explore related searches

Contact this professor

Articles (12)

Assessing the impact of mRNA vaccination in chronic inflammatory murine model

A lipid nanoparticle platform incorporating trehalose glycolipid for exceptional mRNA vaccine safety

Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants

Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates

Effective inactivated influenza vaccine for the elderly using a single-stranded RNA-based adjuvant

Peptides Derived From S and N Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Induce T Cell Responses: A Proof of Concept for T Cell Vaccines

Nanoformulated Single‐Stranded RNA‐Based Adjuvant with a Coordinative Amphiphile as an Effective Stabilizer: Inducing Humoral Immune Response by Activation of Antigen‐Presenting Cells

Nanoformulated Single‐Stranded RNA‐Based Adjuvant with a Coordinative Amphiphile as an Effective Stabilizer: Inducing Humoral Immune Response by Activation of Antigen‐Presenting Cells

Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant

Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection

Lessons learned from sars-cov and mers-cov: Preparation for sars-cov-2 induced covid-19

Mers-cov spike protein vaccine and inactivated influenza vaccine formulated with single strand rna adjuvant induce t-cell activation through intranasal immunization in mice

Collaborators (5)

Mee‐Sup Yoon

Seongeun Bae

Jae‐Hwan Nam

Soyeon Yoo

Youngran Cho

Make your next move.